Pembrolizumab

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12162 publications

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Journal: Future oncology (London, England)
Published: January 23, 2026

Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer.

Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer.

Journal: Technology in cancer research & treatment
Published: January 23, 2026

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studies.

Journal: Immuno-oncology technology
Published: January 22, 2026

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.

Journal: The New England journal of medicine
Published: January 21, 2026

CLINICAL OUTCOMES OF NEUROENDOCRINE CARCINOMA OF THE URINARY BLADDER

CLINICAL OUTCOMES OF NEUROENDOCRINE CARCINOMA OF THE URINARY BLADDER

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 21, 2026

Treatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal.

Treatments for renal cell carcinoma: NICE Pilot Treatment Pathways Appraisal.

Journal: Health technology assessment (Winchester, England)
Published: January 20, 2026

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology
Published: January 20, 2026

Sex differences in thyroid dysfunction onset timing induced by immune checkpoint inhibitors: JADER disproportionality analysis.

Sex differences in thyroid dysfunction onset timing induced by immune checkpoint inhibitors: JADER disproportionality analysis.

Journal: Expert opinion on drug safety
Published: January 19, 2026

Evolving Pharmacotherapy for Bladder Cancer-From Non-Muscle-Invasive to Metastatic Disease-Development of Novel Therapies for BCG-Unresponsive NMIBC

Evolving Pharmacotherapy for Bladder Cancer-From Non-Muscle-Invasive to Metastatic Disease-Development of Novel Therapies for BCG-Unresponsive NMIBC

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 19, 2026

Patterns of systemic treatment for melanoma: An insight on trends and costs between 2019-2023 from the English systemic anti-cancer therapy national database.

Patterns of systemic treatment for melanoma: An insight on trends and costs between 2019-2023 from the English systemic anti-cancer therapy national database.

Journal: EJC skin cancer
Published: January 19, 2026

Robot-Assisted Mediastinoscopic Esophagectomy Following Immunotherapy-Induced Interstitial Pneumonia in a High-Risk Patient with Esophageal Cancer

Robot-Assisted Mediastinoscopic Esophagectomy Following Immunotherapy-Induced Interstitial Pneumonia in a High-Risk Patient with Esophageal Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

A Case of Metaplastic Breast Cancer Treated with Neoadjuvant Chemotherapy Combined with Pembrolizumab

A Case of Metaplastic Breast Cancer Treated with Neoadjuvant Chemotherapy Combined with Pembrolizumab

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
Showing 1-12 of 12,162

Last Updated: 02/24/2026